What is Lyka Labs Price-to-Operating-Cash-Flow?
As of today (2024-06-09), Lyka Labs's share price is ₹106.20.
Lyka Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Lyka Labs's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Lyka Labs's Price-to-Operating-Cash-Flow or its related term are showing as below:
BOM:500259'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 2.94 Max: 205.47
Current: 188.63
During the past 13 years, Lyka Labs's highest Price-to-Operating-Cash-Flow Ratio was 205.47. The lowest was 0.00. And the median was 2.94.
Lyka Labs's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Lyka Labs was -82.10% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -43.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -25.50% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -18.70% per year.
During the past 13 years, Lyka Labs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 82.60% per year. The lowest was -53.30% per year. And the median was -8.70% per year.
Lyka Labs Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Lyka Labs's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lyka Labs Price-to-Operating-Cash-Flow Chart
|
Lyka Labs Annual Data
|
|
Trend |
Jun14 |
Jun15 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
6.83 |
8.08 |
4.91 |
33.38 |
188.19 |
|
Lyka Labs Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
33.38 |
- |
- |
- |
188.19 |
Competitive Comparison of Lyka Labs's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Lyka Labs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lyka Labs's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lyka Labs's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Lyka Labs's Price-to-Operating-Cash-Flow falls into.
Lyka Labs Price-to-Operating-Cash-Flow Calculation
Lyka Labs's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 106.20 | / | 0 |
| = | |
Lyka Labs's Share Price of today is ₹106.20.
Lyka Labs's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Lyka Labs (BOM:500259) Business Description
Traded in Other Exchanges
Address
30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.
Lyka Labs (BOM:500259) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:500259 has been successfully added to your